| |
|
Engineering References |
 |
|
| Solids |
- Actelion Pharmaceuticals Ltd., CH-Allschwil, Drug Product Faclity (DPF)
- Armasuisse; Refurbishment of production for solids, semisolids, liquids and sterile
- AstraZeneca UK Ltd., Egypt, New Solid Forms Production Facility
- Biochemie GmbH, A-Kundl, Expansion Penicillin-Filling
- KRKA, Slowenia, New Weighing Centre
- Lannacher, New Solida Production Site
- Mundipharma GmbH, GMP-upgrade Production and Packaging
- Novartis Produktions GmbH, Production expansion and upgrade for category 3 products
- Novartis Pharma AG, New Usage Concept K405
- Temmler GmbH & Co. KG, New Solids Production
|
|
| Pure Media |
|
|
| Basic Design |
- Genzyme Pharmaceuticals, Tank farm planning
- Siegfried Ltd., Tank farm for solvent disposal, SEZ
- Roche AG, Tank farm VITEX
- Genzyme Pharmaceuticals, Focal Seal
- Merck & Cie. KG, B5 - GMP-Upgrade
- F. Hoffmann-La Roche AG, Multi Purpose Plant for Final Finishing Steps
- Novartis Pharma AG, ST - E25 (Xolair)
- Sanofi Aventis, New laboratory and clean room facility H 769
- Chassot AG, WFI-System
- Similasan AG, HPW - System (highly purified water)
- Institus Straumann SA, Extension of the existing AP-System
- Actelion Pharmaceuticals Ltd., Drug Product Faclity (DPF)
- Novartis Produktions GmbH, Production expansion and upgrade for category 3 products
|
|
| CAD (3D) |
- F. Hoffmann-La Roche AG (now DSM), Vitamin B2
- F. Hoffmann-La Roche AG (now DSM), Tank Farm Biotin
- F. Hoffmann-La Roche AG (now DSM), Biotin Synthese
- Siegfried Ltd., Tank farm for solvent disposal, SEZ
- Jungbunzlauer GmbH, Citric Acid Fermentation
- Genzyme Pharmaceuticals, Reactor Room 1600
- Merck & Cie. KG, B5 - GMP-Upgrade
- Novartis Pharma AG, CEP 2 – Controlled Environmental Processing
- Merck & Cie KG, Multi Purpose Plant for Final Finishing Steps
- Novartis Pharma AG, PHAD Sterile Pilot Plant
- Novartis Pharma AG, ST - E25 (Xolair)
|
|
| Conceptual Design |
- Hoffmann-La Roche AG, Filling station tank farm Biotin
- Hoffmann-La Roche AG, Tank farm Vitamin B2 productions
- F. Hoffmann-La Roche AG (now DSM), Tank Farm Biotin
- F. Hoffmann-La Roche AG (now DSM), Biotin Synthese
- Jungbunzlauer GmbH, Citric Acid Fermentation
- Heraeus, PH 4 – Building MM, New Pharma Production
- Novartis Pharma AG, CEP 2 – Controlled Environmental Processing
- Merck & Cie KG, Multi Purpose Plant for Final Finishing Steps
- Kemira Chemie GmbH, Ferric Chloride Plant
- Quiagen, New production facility "Gänsewiese"
- Novartis Pharma AG, PHAD Sterile Pilot Plant
- Novartis Pharma AG, Prefilled syringe line (SCF-process)
- Pentapharm AG, GMP-Upgrade diagnostics filling
- Chassot AG, WFI-System
- Mepha AG, PW - System (purified water)
- Similasan AG, HPW - System (highly purified water)
- Straumann AG, AP - System
- Actelion Pharmaceuticals Ltd., Drug Product Faclity (DPF)
- KRKA, Slowenia, New Weighing Centre
- Mundipharma GmbH, GMP-upgrade Production and Packaging
- Novartis Pharma AG, New Usage Concept K405
- Temmler GmbH & Co. KG, New Solids Production
|
|
| Construction Management |
- Hoffmann-La Roche AG, Filling station tank farm Biotin
- Hoffmann-La Roche AG, Tank farm Vitamin B2 productions
- F. Hoffmann-La Roche AG (now DSM), Biotin Synthese
- Genzyme Pharmaceuticals, Focal Seal
- Heraeus, PH 4 – Building MM, New Pharma Production
- Novartis Pharma AG, CEP 2 – Controlled Environmental Processing
- Kemira Chemie GmbH, Ferric Chloride Plant
- Bundeswehr-Apotheke ULM, New galenic facility: Dispatch, storage, laboratory
- Berna Biotech AG, Inflexal/ Epaxal
- Novartis Pharma AG, PHAD Sterile Pilot Plant
- Novartis Pharma AG, WST - E25 (Xolair)
- Qiagen, Sterile filling
- Geistlich Pharma, WFI - USP system
- Similasan AG, HPW - System (highly purified water)
- Straumann AG, AP - System
|
|
| Detailed Design |
- Hoffmann-La Roche, Simulation tank farm
- Hoffmann-La Roche AG, Tank farm Vitamin B2 productions
- F. Hoffmann-La Roche AG (now DSM), Biotin Synthese
- F. Hoffmann - La Roche AG (now DSM), Tank Farm Biotin
- Berna Biotech AG, GMP-Upgrade Vivotif Building 78
- Genzyme Pharmaceuticals, Reactor Room 1600
- Novartis Pharma AG, CEP 2 – Controlled Environmental Processing
- SF-Chem, GMP and Occupational Hygiene Upgrade FCP
- Bundeswehr-Apotheke ULM, New galenic facility: Dispatch, storage, laboratory
- CILAG AG, Ansatzlinie 350
- Qiagen, Sterile filling
- Geistlich Pharma, WFI - USP system
- Institus Straumann SA, Extension of the existing AP-System
- Lannacher, New Solida Production Site
|
|
| Logistics |
|
|
| Liquids |
- International Pharmaceutical Producer, Parenteralia Pilot production for highly active substances
- B. Braun, D- Melsungen, Facility planning: New pharmaceutical production
- Berna Biotech AG, Inflexal/ Epaxal
- Boehringer Ingelheim, Biopharma Fill & Finish 2020
- Novartis Pharma AG, Multi purpose Pilot Plant (sterile APIs)
- Novartis Pharma AG, PHAD Sterile Pilot Plant
- Novartis Pharma AG, WST - E25 (Xolair)
- Pentapharm AG, GMP-Upgrade diagnostics filling
- Qiagen, D-Hilden, Sterile filling
- Sanofi Aventis, New laboratory and clean room facility H 769
|
|
| Chemie |
|
|
| Biotechnology |
- Bayer AG, KG3, Factor VIII Production
- Berna Biotech AG, Upgrade Vivotif I
- Berna Biotech AG, GMP-Upgrade Vivotif Building 78
- Berna Biotech AG, Inflexal / Epaxal
- Centeon (Aventis Behring), M300 GMP-Upgrade
- W.C. Heraeus GmbH, D-Hanau, API Production
- Jungbunzlauer GmbH, Citric Acid Fermentation
- F. Hoffmann-La Roche AG (heute DSM), Vitamin B2
- F. Hoffmann-La Roche, MAB - Building 95
- Rhein Biotech, Pilot Plant
|
|
| API |
- Genzyme Pharmaceuticals, Focal Seal
- Genzyme Pharmaceuticals, Reactor Room 1600
- Heraeus, PH 4 - Building MM, New Pharma Production
- Merck & Cie. KG, B5 - GMP-Upgrade
- Merck & Cie KG, Multi Purpose Plant for Final Finishing Steps
- Novartis Pharma AG, CEP 2 - Controlled Environmental Processing
- F. Hoffmann-La Roche AG, Multi Purpose Plant for Final Finishing Steps
- F. Hoffmann - La Roche AG (now DSM), Biotin
- SF-Chem, GMP and Occupational Hygiene Upgrade FCP
|
|
| Biotechnology |
|
|
| Pharma and Vitamins |
|
|
Diagnostics
Medical Devices |
|
|
| Handling of Media |
|
|
|
|
|
| up | back | send per mail | print |
|
|
